ID
20195
Description
Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00243503
Link
https://clinicaltrials.gov/show/NCT00243503
Keywords
Versions (1)
- 2/11/17 2/11/17 -
Uploaded on
February 11, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Neoplasms NCT00243503
Eligibility Breast Neoplasms NCT00243503
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Prior chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C1514457
Description
Hypersensitivity to trastuzumab
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0728747
Description
Study status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Brain metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Similar models
Eligibility Breast Neoplasms NCT00243503
- StudyEvent: Eligibility
C0678222 (UMLS CUI [1,2])
C0278488 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
C0728747 (UMLS CUI [1,2])